Find out more about mapCrowd and the allies that support us!
To address the lack of data and enhance global hepatitis C advocacy efforts, in 2016, Médecins du Monde (MdM) and Treatment Action Group (TAG) launched mapCrowd, an online crowdsourcing platform designed to gather and publicize the most up-to-date country-level information on the hepatitis C virus (HCV). In 2021, the mapCrowd database gained additional support by the Hepatitis C Partnership for Control and Treatment, or Hepatitis C PACT– a partnership among Médecins Sans Frontières, Drugs for Neglected Diseases initiative, Treatment Action Group, and Foundation for Innovative New Diagnostics – the global alliance for diagnostics, to inform country-specific campaigns and national hepatitis planning processes in low- and middle-income countries.
- Médecins du Monde (MdM) works in France and 74 countries worldwide. Doctors of the World - Médecins du Monde is an independent international movement of campaigning activists who provide care, bear witness and support social change. Through 326 innovative medical programmes and evidence-based advocacy initiatives, Médecins du Monde enables excluded individuals and their communities to access health and fight for universal access to healthcare. See https://www.medecinsdumonde.org/
- Treatment Action Group (TAG) is an independent, activist, and community-based research and policy think tank committed to racial, gender, and LGBTQ+ equity; social justice; and liberation, fighting to end HIV, tuberculosis (TB), and hepatitis C virus (HCV). See https://www.treatmentactiongroup.org/
- Médecins Sans Frontières - Doctors without Borders (MSF) provides medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Teams are made up of tens of thousands of health professionals, logistic and administrative staff - bound together by its charter. Actions are guided by medical ethics and the principles of impartiality, independence and neutrality. MSF is a non-profit, self-governed, member-based organization. See https://www.msf.org/
- Drugs for Neglected Diseases initiative (DNDi) was founded in 2003 by MSF, the World Health Organization, and five international research institutions. DNDi discovers, develops, and delivers new treatments for neglected patients around the world that are affordable and patient-friendly – and have already saved millions of lives. See https://dndi.org/
- FIND, the global alliance for diagnostics, seeks to ensure equitable access to reliable diagnosis around the world. FIND connects countries and communities, funders, decisionmakers, healthcare providers and developers to spur diagnostic innovation and make testing an integral part of sustainable, resilient health systems. See https://www.finddx.org/
- Hepatitis C Partnership for Control and Treatment (Hepatitis C PACT) comprises the Drugs for Neglected Diseases initiative (DNDi), Médecins Sans Frontières (MSF), FIND – the global alliance for diagnostics, and the Treatment Action Group (TAG). The Hepatitis C PACT aims to tackle ongoing disparities in access to diagnostics and treatment for hepatitis C virus (HCV) in low-and middle-income countries (LMICs) by by rolling out all-oral cures, scaling up community-based testing, tackling patent and access barriers, and building collaborations with ministries of health, national and provincial programmes, community and civil society groups, and others involved in HCV advocacy.
This website has been produced with the financial support of the French Development Agency (AFD) and Médecins Sans Frontières Transformational Investment Capacity (MSF/TIC). The ideas and opinions expressed do not necessarily represent those of AFD or MSF/TIC.
We gratefully acknowledge Harm Reduction International (HRI) for providing data from the Global State of Harm Reduction report and related research. We thank the Clinton Health Access Initiative for providing technical review on mapCrowd questions and data on diagnostics pricing in the HCV Market Intelligence Report 2021 and Preliminary HBV Market Insights.
We have immense gratitude for the invaluable contributions and information-sharing from our partners and allies at the Africa Hepatitis Initiative, Alliance for Public Health Ukraine, Coalition PLUS, CORRELATION Network, Drugs for Neglected Diseases initiative, European AIDS Treatment Group, FIPRA, Foundation for Innovative New Diagnostics, GAT Portugal, Médecins Sans Frontières Access Campaign, and the World Hepatitis Alliance.
[Download the English briefing document here]
[French briefing document]
[Spanish briefing document]